In a report released today, Ryan Langston from TD Cowen maintained a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. The company’s shares opened today at $89.50.
Simply put, CRO increases the amount customers spend without even realising it. And those flashy digital menus offering 99p burgers for a limited time? They might just be one of the culprits.
Amedisys Inc (NASDAQ:AMED) shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated (NYSE:UNH). In an exchange filing ...
Today’s surge in AMED stock is undoubtedly linked to the ongoing merger drama and the company’s decision to extend its timeline. However, the bigger picture revolves around the merger’s fate and ...
After hours: December 27 at 7:50:21 PM EST Loading Chart for AMED ...
@mentusfentus: 3DS Theme: Fixed crashing when launching apps from top bar without hovering on an icon. @edo9300: Fixed issues when running on SuperCard Rumble flashcarts.